A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Apolipoprotein serum levels related to metabolic side effects in patients with schizophrenia
[post]
2018
unpublished
Preserved Fulltext
Apolipoprotein serum levels related to metabolic side effects in patients with schizophrenia. European Neuropsychopharmacology, 29, S115-S116.
doi:10.26226/morressier.5b68175fb56e9b005965c631
fatcat:uj4lysbuxvgrtinlwubaywkcla